SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is generating significant buzz following positive regulatory advancements for its ANKTIVA therapy, with the FDA outlining a path to resubmission for papillary bladder cancer that requires no new clinical trials. This news, combined with recent international approvals, is fueling strong community sentiment around the potential for a "cancer cure" and intense discussions anticipating a substantial short squeeze.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as market participants react to heightened geopolitical tensions, specifically former President Trump's recent tariff threats against NATO allies over Greenland and an anticipated Supreme Court ruling on presidential tariff authority. This has sparked a fierce debate among investors, with some advocating to "buy the dip" and anticipating a rapid "Taco Trade" rebound, while others warn of a significant market correction. Adding to the volatility are concerns surrounding Japan's bond market instability, creating a complex and uncertain trading environment.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after announcing a non-exclusive license agreement with Pfizer for its Matrix-M adjuvant, providing significant validation for the technology. This deal, building on previous collaborations, is driving community excitement and fueling discussions about the adjuvant's potential applications and the company's future partnerships amidst notable short interest.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as former President Trump's renewed threats of tariffs on NATO allies, particularly over the acquisition of Greenland, spark fears of a trade war with Europe. This escalating geopolitical tension is causing widespread market jitters and calls for caution, though many investors are also discussing it as a potential "buy the dip" opportunity for growth stocks.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares ETF (GLD) is trending strongly as renewed geopolitical tensions, including recent tariff threats concerning European countries over Greenland, fuel a broad flight to safety. The community views gold as a crucial hedge against eroding fiat currency confidence and economic instability, driving prices to consistent new highs. Many are discussing significant further appreciation as these global uncertainties persist.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is currently a major talking point among investors, primarily driven by its upcoming earnings report and the proposed all-cash acquisition of Warner Bros. Discovery assets, which has sparked a debate over potential growth versus debt concerns. The community is closely watching for strong ad-tier performance and subscriber metrics, particularly after a previous tax-related earnings miss, with sentiment split on whether recent oversold conditions signal a significant rebound or continued volatility.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending amid intense debate surrounding the Federal Reserve's independence, fueled by a federal probe into its Chair and the administration's aggressive policy maneuvers impacting bond markets. Investors are actively discussing whether long-term treasuries offer a crucial hedge against a potential economic slowdown or face further headwinds from escalating national debt and geopolitical uncertainty.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin ($APP) is experiencing significant volatility and a notable price decline following a new short report alleging the company's involvement in money laundering. This report has sparked intense debate among investors, with many attributing the drop to market manipulation and viewing it as a buying opportunity, while others express concern over the serious accusations despite recent bullish analyst upgrades.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to overwhelmingly positive data from its Phase 1 clinical trial of soquelitinib for atopic dermatitis, with community discussions highlighting its strong efficacy in treatment-resistant patients. Investors are actively debating the potential for this novel oral ITK inhibitor to disrupt the significant atopic dermatitis market, fueling speculation of future partnerships or an acquisition and validating its broader immune-modulating platform.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending amidst a broader software sector selloff, with community discussion centered on whether AI advancements pose a threat or opportunity. Recent news of a key OpenAI partnership and the strategic acquisition of cybersecurity firm Armis, alongside positive analyst reiterations, fuels debate over the stock's oversold status.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Odysight.ai (NASDAQ:ODYS) Major Shareholder Y.D. More Investments Ltd Sells 323,443 Shares

Odysight.ai Inc. (NASDAQ:ODYS - Get Free Report) major shareholder Y.D. More Investments Ltd sold 323,443 shares of Odysight.ai stock in a transaction on Tuesday, January 6th. The stock was sold at...

Insider Selling: Odysight.ai (NASDAQ:ODYS) Major Shareholder Sells $29,185.00 in Stock

Odysight.ai Inc. (NASDAQ:ODYS - Get Free Report) major shareholder Y.D. More Investments Ltd sold 8,980 shares of the firm's stock in a transaction dated Monday, December 29th. The stock was sold at...

Insider Selling: Odysight.ai (NASDAQ:ODYS) Major Shareholder Sells 8,980 Shares of Stock

Odysight.ai Inc. (NASDAQ:ODYS - Get Free Report) major shareholder Y.D. More Investments Ltd sold 8,980 shares of Odysight.ai stock in a transaction that occurred on Monday, December 29th. The shares...

Odysight.ai (NASDAQ:ODYS) Major Shareholder Sells $11,524.00 in Stock

Odysight.ai Inc. (NASDAQ:ODYS - Get Free Report) major shareholder Y.D. More Investments Ltd sold 3,350 shares of the business's stock in a transaction that occurred on Tuesday, December 23rd. The...

Insider Selling: Odysight.ai (NASDAQ:ODYS) Major Shareholder Sells 3,350 Shares of Stock

Odysight.ai Inc. (NASDAQ:ODYS - Get Free Report) major shareholder Y.D. More Investments Ltd sold 3,350 shares of the business's stock in a transaction on Tuesday, December 23rd. The shares were sold...

Insider Selling: Odysight.ai (NASDAQ:ODYS) Major Shareholder Sells 5,000 Shares of Stock

Odysight.ai Inc. (NASDAQ:ODYS - Get Free Report) major shareholder Y.D. More Investments Ltd sold 5,000 shares of the company's stock in a transaction dated Monday, December 1st. The stock was sold...

Odysight.ai (NASDAQ:ODYS) Major Shareholder Sells $17,250.00 in Stock

Odysight.ai Inc. (NASDAQ:ODYS - Get Free Report) major shareholder Y.D. More Investments Ltd sold 5,000 shares of the business's stock in a transaction dated Monday, December 1st. The stock was sold...

Odysight.ai Inc. $ODYS Shares Purchased by Y.D. More Investments Ltd

Y.D. More Investments Ltd increased its position in Odysight.ai Inc. (NASDAQ:ODYS - Free Report) by 5.6% in the second quarter, according to the company in its most recent Form 13F filing with the...

Odysight.ai (NASDAQ:ODYS) Announces Quarterly Earnings Results

Odysight.ai (NASDAQ:ODYS - Get Free Report) released its earnings results on Thursday. The company reported ($0.27) EPS for the quarter. Odysight.ai had a negative return on equity of 54.92% and a...

Y.D. More Investments Ltd Sells 77,385 Shares of Odysight.ai (NASDAQ:ODYS) Stock

Odysight.ai Inc. (NASDAQ:ODYS - Get Free Report) major shareholder Y.D. More Investments Ltd sold 77,385 shares of Odysight.ai stock in a transaction on Monday, November 10th. The stock was sold at...

Odysight.ai, Inc. engages in the development and manufacture of customized visual solutions for organizations across a variety of industries in the form of micro cameras and supplementary technologies. Its devices can used across the medical, aerospace, industrial, research, and defense industries. The company was founded on March 22, 2013 and is headquartered in Omer, Israel.

ODYS
ScoutCam Inc

Feed

News

Sentiment

Fundamentals

Info

Latest ODYS News

ODYSScoutCam Inc